September 17, 2026 · The American journal of medicine · DOI: 10.1016/j.amjmed.2026.09.006

Calcium Channel Blockers are Safe and Beneficial in Patients with Heart Failure and Advanced Chronic Kidney Disease

Listen to this summary

The authors aimed to evaluate the impact of calcium channel blockers (CCBs) on all-cause mortality in patients with heart failure and advanced chronic kidney disease. Their retrospective cohort study found that CCB use was associated with lower mortality rates, suggesting that CCBs may serve as a beneficial adjunctive therapy for blood pressure control in this high-risk population.

Viana Copeland, Assi Milwidsky, Shir Elimeleh, Noam Makmal, Ranel Loutati, Moti Zwilling, Boris Fishman, Yishay Wasserstrum, Amitai Segev, Elad Maor, Ehud Grossman

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play